INTC
Intel CorporationClose $118.96EOD onlyThis page reflects INTC options positioning from the latest published market-close snapshot. Intraday price and contract changes are not displayed.
Historical consensus-supported lens with full content, report chain context, and metric rail.
You are viewing an older report from March 30, 2026. A newer directional report is available for May 20, 2026.
View latest reportOutlook
Bearish with a strong gravitational pull toward $45 max pain, but facing significant structural headwinds. Confidence: 3/10. The regime is contradictory: bullish flow and pinning target conflict with negative GEX and a spot price far below the pin, suggesting a painful squeeze higher is needed to resolve.
Conflicts: GEX -$9.0M (negative/de-hedging), spot at $41.17 is 8.5% below $45 max pain, MP trend falls to $40 over time.
Regime Classification
Price Range Forecast
Key Levels
Dealer Positioning (GEX/DEX)
GEX: $-9.0M
DEX: +139.5M shares
Gamma flip: ~$15 (Approx — based on put OI concentration of 55,406)
NTM gamma: Gamma flip ~$15 is far below spot, irrelevant for near-term hedging. Negative GEX means dealers are net short gamma; their hedging (buying high, selling low) will amplify spot moves in either direction.
IV Analysis
IV vs VIX: IV 72.2% — extremely elevated, offering rich premium for sellers. Implied move for 12 days is ±9.1%.
Term structure: Steeply inverted near-term: 4-day IV 70.7% > 12-day IV 63.1%. Hump at 4/24 (70.4%) likely pricing an event. Longer-dated IV ~61-65%.
Skew: High near-term IV vs. lower 30-45 DTE IV creates a ~7 vol-pt differential, favoring calendar spreads selling the front week.
Flow Analysis
Net premium: +$15.1M bullish; P/C vol 0.39 (extreme call skew), P/C OI 0.88.
Directional prints: $42C 4/24 vol 10,469 vs OI 39 (268x) — large, likely bought call flow targeting post-event move. $42C 4/2 vol 2,073 vs OI 256 — near-term bullish bet. Interpretation: Consistent with bullish flow regime, these are likely long calls or call spreads.
Unusual: $36C 5/8 vol 178 vs OI 1 at IV 88.8% — deep OTM call sweep, possibly a cheap lottery ticket or part of a complex spread.
Risks & Catalysts
Strategy Viability
| Strategy | Edge | Best Setup | Primary Risk |
|---|---|---|---|
| Long stock | Moderate-Weak | Buy shares at $41.17 | Negative GEX and distance to pin increase drawdown risk before any squeeze. |
| Short stock | Weak | Sell shares at $41.17 | Strong bullish flow and max pain gravity create potent squeeze risk. |
| Covered call | Moderate-Strong | Buy stock, sell $45C 4/10 or 4/17 (~$1.00-1.50 credit) | Stock rallies past $45, shares called away; negative GEX increases volatility. |
| Cash-secured put / put spread | Moderate | Sell $38/$35 put spread 4/17 (EM low bound vs. put floor) | Negative GEX accelerates breakdown below support. |
| Long calls | Moderate-Weak | Buy $42C 4/17 | High IV and negative GEX make timing difficult; pin may take weeks to resolve. |
| Long puts / bear put spreads | Weak | Avoid — contradicts strong bullish flow and pin. | Squeeze risk. |
| Iron condor | Moderate | $38P/$35P x $45C/$48C 4/17 (bounds: EM low & max pain/EM high) | Negative GEX (trending) violates range-bound assumptions; VIX context unknown but high IV helps. |
| Calendar/diagonal | Moderate-Strong | Sell $45C 4/2 (IV 70.7%), buy $45C 4/17 (IV 64.6%) — reverse calendar (sell near, buy far). | Spot moves sharply away from $45, eroding long leg value. |
| PMCC / LEAPS diagonal | Moderate | Buy $35C Jan 2027, sell $45C 4/17 or 5/1 against it. | Capital intensive; near-term pin may not materialize, decaying short leg. |
Top Plays
Watchlist Triggers
Tactical Summary
Each report translates the same market-close options snapshot into a specific lens such as directional bias, premium-selling posture, flow quality, or earnings setup.
Reports are most useful for narrowing the playbook, surfacing entry and risk context, and deciding which raw data page to inspect next.
These are interpretation layers, not execution guarantees. Validate the setup against chain liquidity, expected move, and exposure before sizing risk.